Status:
COMPLETED
Video-observed Therapy for Active Tuberculosis: a Feasibility Study
Lead Sponsor:
Ligue Pulmonaire Genevoise
Collaborating Sponsors:
University Hospital, Geneva
Conditions:
Tuberculosis Active
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Tuberculosis (TB) is still present in Switzerland, and concerns mainly foreign-born subjects. Monitoring compliance to treatment by Directly Observed Therapy (DOT) is strongly encouraged by the World ...
Detailed Description
The study aims to include all patients who are treated de novo for active tuberculosis is our area. The aim of this study, was to show that vDOT was feasible in a low-incidence high income area, that ...
Eligibility Criteria
Inclusion
- age above 16 years of age; providing informed consent (translators were used whenever necessary to ensure understanding of study and vDOT procedure); having a diagnosis of untreated active tuberculosis, irrespective of site of infection, confirmed by culture and/or Polymerase chain reaction test (PCR) and follow-up ensured by Geneva University Hospital.
Exclusion
- refusal to participate, not fulfilling inclusion criteria
Key Trial Info
Start Date :
November 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT06574529
Start Date
November 26 2021
End Date
May 31 2024
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospital
Geneva, Canton of Geneva, Switzerland, 1205